Print Page  Close Window

Press Release

Depomed to Present at Healthcare Conferences in February

NEWARK, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare conferences during the month of February.

LEERINK Partners 6th Annual Global Healthcare Conference

Date: Wednesday, February 15, 2017
Time: 3:30 p.m. EST
Location: New York, New York

RBC Capital Markets 2017 Global Healthcare Conference

Date: Thursday, February 23, 2017
Time: 8:00 a.m. EST
Location: New York, New York

The fireside chats will be webcast live and may be accessed via the Investor Relations page of the Depomed website at  A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit


Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications

Primary Logo

Depomed, Inc